Gian Luca Araldi

This inventor holds 28 USPTO granted patents and 3 published patent applications and 2 EPO patents, primarily in Prostaglandin Modulators. Top assignees: Georgetown University, Laboratoires Serono S.a., Corvas International, Inc.. Active years: 2001-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gian Luca Araldi. Retrieved from https://idiyas.com/inventor/gian-luca-araldi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 3)

% Patents Active = 39.3

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 3.0

ph-index = 8

Forward Citations = 208(Granted Patents)

Location History:

Washington, DC (US) (2001 - 2004)
Quincy, MA (US) (2004)
Smithtown, NY (US) (2007)
Sedauket, NY (US) (2008 - 2010)
San Diego, CA (US) (2002 - 2011)
Plymouth, MA (US) (2007 - 2011)

Company Filing History:

11 out of 499

Georgetown University

patents

4 out of 40

Laboratoires Serono S.a.

patents

3 out of 75

Corvas International, Inc.

Applied Research Systems Ars Holding N.v.

patents

6. 1 out of 3

Biostream Therapeutics, Inc.

Dendreon San Diego LLC

patent

9. 2 out of 834,513

Other

patents

Years Active: 2001-2011

Loading Chart...

Areas of Expertise:

Prostaglandin Modulators

CNS Injury Treatment

Neurodegenerative Disorders

NMDA Receptor Ligands

Bicyclic Ligands

Thrombin Inhibitors

Cyclic Dipeptides

Pyrazolidinone Compounds

Pyrrolidine Derivatives

Hydrazide Derivatives

Tropane Derivatives

Gamma Lactams

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8058305 - Pyrrolidine derivatives as prostaglandin modulators (2011-11-15),

2. 8044103 - Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders (2011-10-25),

3. 7863312 - Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors (2011-01-04),

4. 7696243 - [object Object] (2010-04-13),

5. 7635713 - Pyrrolidine derivatives as prostaglandin modulators (2009-12-22),

6. 7465755 - Hydrazide derivatives as prostaglandin receptors modulators (2008-12-16),

7. 7419999 - Gamma lactams as prostaglandin agonists and use thereof (2008-09-02),

8. 7410991 - Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors (2008-08-12),

9. 7335680 - Pyrrolidine derivatives as prostaglandin modulators (2008-02-26),

10. 7276531 - G-lactam derivatives as prostaglandin agonists (2007-10-02),

11. 7202279 - Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders (2007-04-10),

12. 7157596 - Inhibitors of serine protease activity of matriptase or MTSP1 (2007-01-02),

13. 6825211 - Bicyclic metabotropic glutamate receptor ligands (2004-11-30),

14. 6806281 - Analogs of cocaine (2004-10-19),

15. 6797504 - Inhibitors of serine protease activity of matriptase or MTSP1 (2004-09-28),

Title: The Innovations of Gian Luca Araldi: Enhancing Healthcare and Neuroprotection

Introduction: Gian Luca Araldi, a prolific inventor based in San Diego, CA, has made significant contributions to the fields of healthcare and neuroprotection through his groundbreaking inventions and patents.

Latest Patents: Gian Luca Araldi's latest patents include the development of pyrrolidine derivatives as prostaglandin modulators. These compounds offer a novel approach to treating a range of health conditions such as preterm labor, asthma, infertility, and bone disorders. Additionally, his work on cyclic dipeptides and azetidinone compounds demonstrates a promising avenue for enhancing memory and treating neurological disorders, especially those caused by CNS trauma.

Career Highlights: With an impressive portfolio of 28 patents, Gian Luca Araldi has established himself as a leading innovator in the medical field. His pioneering research has not only improved existing treatments but also opened up new possibilities for addressing challenging medical conditions.

Collaborations: Throughout his career, Gian Luca Araldi has collaborated with esteemed colleagues such as Alan P Kozikowski and Zhong Zhao. His partnerships with notable researchers and institutions, including Georgetown University and Laboratoires Serono S.a., have played a pivotal role in advancing his work and bringing innovative solutions to the forefront.

Conclusion: In conclusion, Gian Luca Araldi's inventive spirit and dedication to improving healthcare and neuroprotection have undoubtedly left a lasting impact on the field of medicine. His patents reflect a commitment to innovation and a relentless pursuit of solutions that have the potential to transform the lives of many.

Profile summary based on public USPTO records.